article thumbnail

Accelerator Life Science Partners Launches Biotechnology Startup Company in Singapore with $16M in Series A Commitments

Digital Health Global

With these resources, Automera is well positioned to deploy our AUTAC platform toward the development of potentially transformative therapies.” Automera’s AUTAC platform has broad potential across cancer and other disease areas, with oncology being the initial lead program.